tci Medicare Compliance & Reimbursement - 2003 Issue 17
Medicaid Drugs: LEGISLATIVE OFFICE URGES FLORIDA TO DUMP PFIZER MEDICAID PROGRAM
Saying it hasn't seen solid evidence of significant savings produced by disease-management and other services being provided to Florida Medicaid by pharmaceutical makers in lieu of deep drug discounts, the state legislature's Office of Program Policy Analysis and Government Accountability is calling for repeal of the programs, which include a highly touted DM initiative conducted by Pfizer. The state's mandatory preferred-drug list and negotiated supplemental rebates saved Florida and the federal government $81 million in fiscal year 2001-2002, despite the fact that not all therapeutic categories have yet been reviewed for the list, says an April report from the...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Thank you for choosing Find-A-Code, please Sign In to remove ads.